AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 10762288
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose GH therapy (2 U daily, n = 5)
Trial: 10762288
Drug: GH therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH therapy after placebo (n = 5)
Trial: 1597852
Drug: Purified caffeine
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Purified caffeine (200 mg)
Trial: 31206607
Drug: 2.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg/kg rabbit anti-thymocyte globulin (ATG) for 5 days
Trial: 31206607
Drug: 3.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.5 mg/kg rabbit anti-thymocyte globulin (ATG) for 5 days
Trial: 20523078
Drug: Oral risperidone
RxNorm normalized name: Risperidone
DrugBank: Risperidone (DB00734)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Oral risperidone orodispersible tablet
Trial: 18670740
Drug: Irbesartan (150-300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irbesartan (150-300 mg)
Trial: 18670740
Drug: Quinapril (20-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinapril (20-40 mg)
Trial: 16440578
Drug: Calcipotriol cream
RxNorm normalized name: calcipotriol
DrugBank: Calcipotriol (DB02300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcipotriol cream applied once daily
Trial: 16440578
Drug: Calcipotriol cream
RxNorm normalized name: calcipotriol
DrugBank: Calcipotriol (DB02300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcipotriol cream applied twice daily
Trial: 8889909
Drug: Fluvoxamine (100-150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvoxamine (100-150 mg/day)
Trial: 1907963
Drug: Fluoxetine (20-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (20-80 mg/day)
Trial: 1380148
Drug: CODE chemotherapy
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CODE chemotherapy with recombinant human granulocyte colony-stimulating factor
Trial: 1380148
Drug: CODE chemotherapy
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CODE chemotherapy without recombinant human granulocyte colony-stimulating factor
Trial: 29505471
Drug: GSK561679 (CRHR1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSK561679 (CRHR1 antagonist)
Trial: 27178257
Drug: DAGR 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DAGR 1 mg QD
Trial: 27178257
Drug: DAGR 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DAGR 5 mg QD
Trial: 27178257
Drug: DAGR 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DAGR 10 mg QD
Trial: 27178257
Drug: DAGR 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DAGR 15 mg QD
Trial: 27178257
Drug: DAGR 9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DAGR 9 mg QD
Trial: 27178257
Drug: Prednisone 5
RxNorm normalized name: prednisone 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone 5 mg QD
Trial: 27178257
Drug: Prednisone 10
RxNorm normalized name: prednisone 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone 10 mg QD
Trial: 16385833
Drug: Single-dose internal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose internal brachytherapy (12 Gy)
Trial: 9279536
Drug: euglycaemic hyperinsulinaemia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: euglycaemic hyperinsulinaemia (HI) with plasma insulin at 80 mUL‐1 and glucose at 4‐5 mmolL‐1
Trial: 6882619
Drug: Ibopamine 200
RxNorm normalized name: ibopamine
DrugBank: Ibopamine (DB13316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibopamine 200 mg
Trial: 3209280
Drug: Furosemide 40
RxNorm normalized name: furosemide 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide 40 mg plus Ibopamine 200 mg
Trial: 11714065
Drug: Terbinafine 1%
RxNorm normalized name: Terbinafine 1% Topical application Gel/Jelly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbinafine 1% cream, applied once daily for 7 days
Trial: 29550384
Drug: Reduced-intensity conditioning
RxNorm normalized name: ALLANTOIN 1 g in 100 g TOPICAL CREAM [Scar Reducer Intensive Herbal and Nutrient]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reduced-intensity conditioning (120 mg/m2 fludarabine + 4 doses of 2 Gy total-body irradiation)
Trial: 29550384
Drug: Myeloablative conditioning
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Myeloablative conditioning (6 doses of 2 Gy total-body irradiation + 120 mg/kg cyclophosphamide)
Trial: 25154982
Drug: Bevacizumab 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bevacizumab 7.5 mg/kg or 15 mg/kg plus chemotherapy
Trial: 20818474
Drug: BCAAs supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCAAs supplementation (0.4 g/kg/day and 0.2 g/kg/day)
Trial: 17362472
Drug: Budesonide/formoterol 160/4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide/formoterol 160/4.5 microg one inhalation bid plus additional inhalations as needed
Trial: 17362472
Drug: Fixed-dose budesonide/formoterol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-dose budesonide/formoterol 320/9 microg one inhalation bid plus as-needed terbutaline
Trial: 15102873
Drug: Intravenous palonosetron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous palonosetron (0.3 to 90 microg/kg)
Trial: 24587006
Drug: Intravenous palonosetron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous palonosetron
Trial: 11581434
Drug: Educational video
RxNorm normalized name: DIABETES PATIENT EDUCATION PACK
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Educational video intervention (20-minute video and brochure about antibiotics)
Trial: 9704672
Drug: Three-drug combination
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-drug combination of docetaxel (75 mg/m2), ifosfamide (3,000 mg/m2), and cisplatin (75 mg/m2) with lenograstim support
Trial: 9704672
Drug: Three-drug combination
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-drug combination of docetaxel, ifosfamide, and cisplatin
Trial: 7991433
Drug: Iron supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplementation with iron sulfate 5 mg/kg until day 56
Trial: 2567483
Drug: Sotalol (320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sotalol (320 mg.d‐1)
Trial: 2567483
Drug: Propranolol (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (160 mg.d‐1)
Trial: 2567483
Drug: Atenolol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (100 mg.d‐1)
Trial: 5124439
Drug: Pyrantel embonate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyrantel embonate 100 mg/kg
Trial: 5124439
Drug: Pyrantel embonate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyrantel embonate 75 mg/kg
Trial: 5124439
Drug: Pyrantel embonate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyrantel embonate 50 mg/kg
Trial: 5124439
Drug: Pyrantel embonate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyrantel embonate 20 mg/kg
Trial: 5124439
Drug: Pyrantel embonate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyrantel embonate 15 mg/kg
Trial: 5124439
Drug: Pyrantel embonate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyrantel embonate 10 mg/kg
Trial: 28627029
Drug: Test cream
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test cream (moisturizer containing urea, glycerine, and petrolatum)
Trial: 23792400
Drug: Four bar-connected
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four bar-connected implants
Trial: 23792400
Drug: Six bar-connected
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Six bar-connected implants
Trial: 22013797
Drug: Reduning Injection
RxNorm normalized name: Iron, reduced
DrugBank: Iron (DB01592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reduning Injection (RI)
Trial: 22013797
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Reduning Injection with Ribavirin Injection or antibiotics
Trial: 15072892
Drug: Androgen deprivation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Androgen deprivation therapy (gonadotropin‐releasing hormone agonist or bilateral orchiectomy)
Trial: 11424777
Drug: Meperidine 75
RxNorm normalized name: MEPERIDINE 75MG/ML INJ CARPUJECT LL 1ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meperidine 75 mg i.m.
Trial: 11424777
Drug: Tramadol 100
RxNorm normalized name: tramadol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 100 mg i.m.
Trial: 9105521
Drug: High-dose immunotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose immunotherapy (HDI) group (MTD >= 4 micrograms Der p 1)
Trial: 9105521
Drug: Conventional immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional immunotherapy (CI) group (MTD < 4 micrograms Der p 1)
Trial: 8394858
Drug: Intravenous ganciclovir,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ganciclovir, 5 mg/kg twice daily for 14 days followed by 5 mg/kg once daily for 14 weeks
Trial: 8394858
Drug: Deferred treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deferred treatment (control)
Trial: 2941267
Drug: Stepped care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stepped care antihypertensive therapy
Trial: 23039014
Drug: Garlic tablets
DrugBank: Garlic (DB10532)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Garlic tablets (2 tablets daily for 1 month)
Trial: 23039014
Drug: Placebo tablets
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablets (2 tablets daily for 1 month)
Trial: 19253204
Drug: Sitagliptin 50
RxNorm normalized name: SITagliptin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitagliptin 50 mg b.i.d.
Trial: 18353996
Drug: Sitagliptin 100
RxNorm normalized name: SITagliptin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitagliptin 100 mg b.i.d.
Trial: 10064669
Drug: TTS-fentanyl (transdermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TTS-fentanyl (transdermal fentanyl system)
Trial: 7586783
Drug: Azapropazone (APZ)
RxNorm normalized name: azapropazone
DrugBank: Azapropazone (DB07402)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azapropazone (APZ) 300 mg t.i.d. for three weeks
Trial: 2405747
Drug: Triamcinolone acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone acetonide aerosol (25 mg per actuation, qid, for 4 weeks)
Trial: 29210815
Drug: Advice from
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Advice from home care nurses on fiber intake, liquid intake, mobilization, laxative administration, and physician referral
Trial: 26373705
Drug: Laxative therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laxative therapy (lactulose and enemas)
Trial: 15223721
Drug: Newer drugs
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Newer drugs (ACE inhibitors, calcium antagonists)
Trial: 15223721
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (diuretics, beta-blockers)
Trial: 9161624
Drug: Ondansetron 32
RxNorm normalized name: ondansetron 32 MG in 50 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 32 mg i.v. over 15 minutes
Trial: 3508564
Drug: Three production
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three production lots of macrocrystalline nitrofurantoin capsules (Macrodantin)
Trial: 3508564
Drug: Capsules from
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsules from one production lot administered on three occasions
Trial: 25992866
Drug: Postoperative cold
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative cold patch
Trial: 25992866
Drug: Wash group
RxNorm normalized name: Zencia Wash
DrugBank: Octasulfur (DB09353)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wash group (ice-cold balanced salt solution)
Trial: 22616762
Drug: SRT2104 (doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SRT2104 (doses ranging from 0.03 to 3.0 g)
Trial: 22303708
Drug: Probucol Tablet
RxNorm normalized name: Probucol Tablets
DrugBank: Probucol (DB01599)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Probucol Tablet (PT) 0.5 g, twice daily
Trial: 22303708
Drug: Lumbrukinase Capsule
RxNorm normalized name: lumbrokinase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lumbrukinase Capsule (LC) 600 thousand U, thrice daily + Probucol Tablet (PT)
Trial: 14982689
Drug: 12 mg
RxNorm normalized name: pectin 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 mg nicotine
Trial: 14982689
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg nicotine
Trial: 14982689
Drug: Repeated dosing
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated dosing with The Straw
Trial: 11502768
Drug: 131I plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 131I plus pretreatment with methimazole (30 mg/d)
Trial: 9248982
Drug: Postoperative antiprostaglandins
RxNorm normalized name: Prostaglandin D2
DrugBank: Prostaglandin D2 (DB02056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative antiprostaglandins and H2-blockers
Trial: 3777409
Drug: Nalbuphine 10
RxNorm normalized name: nalbuphine 10 mg/mL injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nalbuphine 10 mg
Trial: 3544982
Drug: Nalbuphine 10
RxNorm normalized name: nalbuphine 10 mg/mL injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nalbuphine 10 mg plus Hydroxyzine 50 mg
Trial: 24838062
Drug: Cryotherapy and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cryotherapy and BSS-BSSG mixture (20 mg sterol and 0.2 mg sterolin)
Trial: 21086166
Drug: Esomeprazole 40
RxNorm normalized name: esomeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 40 mg bid for 1 week
Trial: 16937744
Drug: 3-3 group,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-3 group, 1 drop 3 times daily for 2 years
Trial: 16937744
Drug: 2-3 group,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-3 group, 1 drop twice daily in year 1 and 1 drop 3 times daily in year 2
Trial: 16937744
Drug: 1-3 group,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-3 group, 1 drop once daily in year 1 and 1 drop 3 times daily in year 2
Trial: 10374174
Drug: Control group,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group, no treatment
Trial: 7492863
Drug: Chlorthalidone (12.5-25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone (12.5-25 mg/day)
Trial: 6803944
Drug: Azathioprine (2-2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azathioprine (2-2.5 mg/kg body weight over six months)
Trial: 25069770
Drug: Milbemax® (milbemycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milbemax® (milbemycin oxime/praziquantel) at a minimum target dose of 0.5 mg/kg bodyweight and 5 mg/kg bodyweight respectively, administered once every 4 weeks.
Trial: 25069770
Drug: Untreated group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Untreated group (T2) receiving specific parasiticide treatments when necessary.
Trial: 22705017
Drug: Non-prescribed Chinese
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-prescribed Chinese herbal medicine (CHM)
Trial: 18382796
Drug: Fentanyl 25
RxNorm normalized name: FENTANYL 25MCG/HR PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 25 micrograms with midazolam 1 mg IV
Trial: 18382796
Drug: Remifentanil 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil 0.3 microgram/kg with midazolam 1 mg IV
Trial: 15755572
Drug: HIV plasmid
RxNorm normalized name: plasmin
DrugBank: Fibrinolysin (DB05254)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIV plasmid vaccine (combination of two HIV DNA plasmid constructs)
Trial: 15755572
Drug: HIV plasmid
RxNorm normalized name: plasmin
DrugBank: Fibrinolysin (DB05254)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIV plasmid vaccine
Trial: 12093983
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (emollients and topical corticosteroids)
Trial: 9585803
Drug: Oral artemisinin
RxNorm normalized name: artemisinin
DrugBank: Artemisinin (DB13132)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral artemisinin (500 mg daily)
Trial: 9585803
Drug: Rectal artemisinin
RxNorm normalized name: artemisinin
DrugBank: Artemisinin (DB13132)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal artemisinin (500 mg daily)
Trial: 9585803
Drug: Rectal artemisinin
RxNorm normalized name: artemisinin
DrugBank: Artemisinin (DB13132)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal artemisinin
Trial: 9585803
Drug: Oral artemisinin
RxNorm normalized name: artemisinin
DrugBank: Artemisinin (DB13132)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral artemisinin
Trial: 3525317
Drug: Levamisole (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levamisole (150 mg/day, 3 days/week)
Trial: 29790612
Drug: 0.5 MHz,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 MHz, invasive, bipolar RF treatment with longer conduction time and lower power (LC/LP)
Trial: 29790612
Drug: 0.5 MHz,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 MHz, invasive, bipolar RF treatment with shorter conduction time and higher power (SC/HP)
Trial: 23678153
Drug: delayed golimumab
RxNorm normalized name: Golimumab
DrugBank: Golimumab (DB06674)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: delayed golimumab treatment (Group 1)
Trial: 788820
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g ascorbic acid per day
Trial: 19818690
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g ascorbic acid per day
Trial: 9145445
Drug: Lactulose (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactulose (2 x 10 g/d)
Trial: 9145445
Drug: Lactitol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactitol (2 x 10 g/d)
Trial: 2122422
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of aminophylline
Trial: 2122422
Drug: Phase 1
RxNorm normalized name: Coxiella burnetii phase 1 IgA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phase 1 (Theo-24 6 mg/kg with 100 ml of water)
Trial: 690225
Drug: Systems Releasing
RxNorm normalized name: Vaginal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systems Releasing Action Therapy (SRAT)
Trial: 29306232
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate 100 μg per day
Trial: 29306232
Drug: Montelukast 4/5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast 4/5 mg per day
Trial: 24823842
Drug: Tobacco Tactics
RxNorm normalized name: Tobacco leaf
DrugBank: Tobacco leaf (DB10710)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tobacco Tactics intervention (nurse counseling, brochure, DVD, manual, pharmaceuticals, 1‐800‐QUIT‐NOW card, post‐discharge telephone calls)
Trial: 20558967
Drug: Strength training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Strength training conducted twice a week for 12 weeks.
Trial: 18182669
Drug: Reduced induction
RxNorm normalized name: Iron, reduced
DrugBank: Iron (DB01592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reduced induction therapy (no anthracyclines) for SR patients
Trial: 18182669
Drug: Conventional BFM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional BFM schedule intensified with three chemotherapy blocks followed by a double reinduction phase for HR patients
Trial: 10384893
Drug: Noise exposure
RxNorm normalized name: Anthrax, post-exposure prophylaxis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Noise exposure with stimulus combination L1 = 65 dB, L1‐L2 = 25 dB, f2/f1 = 1.18
Trial: 6766653
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate (40 mg four times daily for 3 months)
Trial: 6766653
Drug: Placebo (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (40 mg four times daily for 3 months)
Trial: 30822774
Drug: F17464, 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: F17464, 20 mg twice daily
Trial: 25540069
Drug: Intraoperative morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraoperative morphine guided by ANI
Trial: 25540069
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (intraoperative morphine guided by anaesthetist with ANI concealed)
Trial: 23993224
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg intravenous ketorolac preoperatively
Trial: 21813441
Drug: Active training
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active training treatment (strength training)
Trial: 15099455
Drug: Home-administered influenza
RxNorm normalized name: INFLUENZA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-administered influenza vaccination